REFERENCES
- Gerber J G, Nies A S. Antihypertensive agents and the drug therapy of hypertension. Goodman and Gilman's The Pharmacological Basis of Therapeutics, G A Goodman, T W Rall, A S Nies, P Taylor. 8th, Pergamon Press, Inc., New York 1990; 801–803
- Zappacosta A R. Reversal of baldness in patient receiving minoxidil for hypertension. N Engl J Med 1980; 303: 1480–1481
- Meisheri K D, Cipkus L A, Taylor C J. Mechanism of action of minoxidil sulfate-induced vasodilation: A role for increased k permeability. J Pharmacol Exp Ther 1988; 245: 751–760
- Gottlieb T B, Thomas R C, Chidsey C A. Pharmacokinetic studies of minoxidil. Clin Pharmacol Ther 1972; 13: 436–441
- Rogaine® package insert, Upjohn Company. Physicians' Desk Reference, N J Oradell. 49th, Medical Economics. 1995; 2578–2581
- MacMillan A R, Warshawski F J, Steinberg R A. Minoxidil overdose. Chestr 1993; 103: 1290–1291
- Poff S W, Rose S R. Minoxidil overdose with ECG changes: Case report and review. J Emerg Med 1992; 10: 53–57
- Zarate A, Gelfand M C, Horton J D, et al. Pericardial effusion associated with minoxidil therapy in dialyzed patients. Int J Artif Organs 1980; 3: 15–17
- Krehlik J M, Hindson D A, Crowley J J, Jr., Knight L L. Minoxidil-associated pericarditis and fatal cardiac tamponade. West J Med 1985; 143: 527–529
- McCormick M A, Forman M H, Manoguerra A S. Severe toxicity from ingestion of a topical minoxidil preparation. Am J Emerg Med 1989; 7: 419–421